USAGE OF A RAPID DIAGNOSTIC TEST FOR MALARIA IN CHILDREN

Céline Nguefeu Nkenfou1,2, Vestale Ngo Hell3, Nguefack-Tsague Georges4

  • 1Laboratory of Systems Biology, "Chantal Biya" International Reference Centre for Research on HIV/AIDS Prevention and Management (CBIRC), Yaounde, Cameroon.

Insights

The SD Bioline Malaria Antigen rapid diagnostic test (RDT) showed lower performance than WHO recommendations for diagnosing malaria in children. It is best used in resource-limited settings with clinical support.

Area of Science:

  • Medical Diagnostics
  • Infectious Diseases
  • Pediatrics

Background:

  • Malaria remains a leading cause of mortality in children globally.
  • Accurate and rapid diagnosis is crucial for effective pediatric malaria management.
  • Rapid diagnostic tests (RDTs) require thorough pre-commercialization evaluation.

Purpose of the Study:

  • To evaluate the diagnostic performance of the SD Bioline Malaria Antigen P.f/Pan rapid test in children.
  • To compare RDT results against microscopy for malaria diagnosis in a pediatric cohort.

Main Methods:

  • A study was conducted on 249 children (6 months–15 years) presenting with fever.
  • Blood samples were tested using microscopy (thick blood smear) and the SD Bioline Malaria Antigen P.f/Pan RDT.
  • Data was collected between April and October 2014 at the "Chantal Biya" Foundation's Mother and Child Center.

Main Results:

  • Malaria prevalence was 30.9% by microscopy and 58.2% by RDT.
  • The RDT demonstrated a sensitivity of 75%, specificity of 48.8%, positive predictive value of 39%, and negative predictive value of 81.6% compared to microscopy.
  • These performance metrics fall below the World Health Organization's recommended sensitivity threshold (>95%) for RDTs in children.

Conclusions:

  • The SD Bioline Malaria Antigen P.f/Pan test exhibits suboptimal performance for pediatric malaria diagnosis.
  • Its use is recommended primarily in peripheral health facilities with limited resources.
  • Clinical diagnosis should supplement RDT results in these settings to ensure accurate malaria management.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
295
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
568
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
325
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
532